Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vose

Showing results (31-40 of 891) with videos related to

Pageof 90
Sort By:
Seminars in Hematology|October 26, 1999
Antibody-targeted therapy for low-grade lymphomaJ M Vose
Tree Physiology|November 24, 1999
Interspecific and environmentally induced variation in foliar dark respiration among eighteen southeastern deciduous tree speciesMitchell, Bolstad, Vose
Tree Physiology|November 24, 1999
Foliar temperature-respiration response functions for broad-leaved tree species in the southern AppalachiansBolstad, Mitchell, Vose
International Journal of Cancer|August 15, 1982
Quantitation of proliferative and cytotoxic precursor cells directed against human tumours: limiting dilution analysis in peripheral blood and at the tumour siteB M Vose
Oncology (Williston Park, N.Y.)|September 23, 2015
Julie M. Vose, MD, President of ASCO--and Editor-in-Chief of ONCOLOGY--Discusses Her New Role and the Importance of Investing Wisely in Cancer ResearchJulie M Vose
Blood|January 27, 2018
Peripheral T-cell lymphoma: novel backboneJulie M Vose
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1996
Classification and clinical course of low-grade non-Hodgkin's lymphomas with overview of therapyJ M Vose
The New England Journal of Medicine|December 7, 1995
Treatment for non-Hodgkin's lymphoma in relapse. What are the alternatives?J M Vose
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 15, 1998
High-dose chemotherapy and hematopoietic stem cell transplantation for relapsed or refractory diffuse large-cell non-Hodgkin's lymphomaJ M Vose
Clinical Advances in Hematology & Oncology : H&O|April 10, 2015
Commentary: diagnostic dilemmas that impact treatment decisions in lymphomaJulie M Vose
Pageof 90

Showing results (31-40 of 891) with videos related to

Sort By:
Pageof 90
Seminars in Hematology|October 26, 1999
Antibody-targeted therapy for low-grade lymphomaJ M Vose
Tree Physiology|November 24, 1999
Interspecific and environmentally induced variation in foliar dark respiration among eighteen southeastern deciduous tree speciesMitchell, Bolstad, Vose
Tree Physiology|November 24, 1999
Foliar temperature-respiration response functions for broad-leaved tree species in the southern AppalachiansBolstad, Mitchell, Vose
International Journal of Cancer|August 15, 1982
Quantitation of proliferative and cytotoxic precursor cells directed against human tumours: limiting dilution analysis in peripheral blood and at the tumour siteB M Vose
Oncology (Williston Park, N.Y.)|September 23, 2015
Julie M. Vose, MD, President of ASCO--and Editor-in-Chief of ONCOLOGY--Discusses Her New Role and the Importance of Investing Wisely in Cancer ResearchJulie M Vose
Blood|January 27, 2018
Peripheral T-cell lymphoma: novel backboneJulie M Vose
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1996
Classification and clinical course of low-grade non-Hodgkin's lymphomas with overview of therapyJ M Vose
The New England Journal of Medicine|December 7, 1995
Treatment for non-Hodgkin's lymphoma in relapse. What are the alternatives?J M Vose
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 15, 1998
High-dose chemotherapy and hematopoietic stem cell transplantation for relapsed or refractory diffuse large-cell non-Hodgkin's lymphomaJ M Vose
Clinical Advances in Hematology & Oncology : H&O|April 10, 2015
Commentary: diagnostic dilemmas that impact treatment decisions in lymphomaJulie M Vose
Pageof 90